These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6208400)

  • 21. Visualization of urothelial blood group isoantigens A and B using direct biotin-labeled antibodies and avidin-biotin-peroxidase complex.
    Lin CW; Fujime M; Kirley SD; Prout GR
    J Histochem Cytochem; 1984 Dec; 32(12):1139-43. PubMed ID: 6209329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prognostic factors for progression of superficial bladder cancer].
    Sato N; Sumiya H; Isaka S; Shimazaki J; Matsuzaki O
    Nihon Hinyokika Gakkai Zasshi; 1992 Aug; 83(8):1263-9. PubMed ID: 1405165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoclonal antibodies to detect A, B and H blood group isoantigens in superficial transitional cell carcinoma of the bladder: a means of predicting invasive recurrences.
    Stephenson TJ; Williams JL; Gelsthorpe K
    Br J Urol; 1985 Apr; 57(2):148-53. PubMed ID: 3886066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ABH isoantigens in bladder carcinoma patients grouped according to DNA changes over time.
    Borgström E; Gustafson H
    Scand J Urol Nephrol; 1987; 21(2):125-30. PubMed ID: 3616504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of ABH blood group isoantigen as a prognostic factor in transitional cell bladder carcinoma.
    Malmström PU; Busch C; Norlen BJ; Andersson B
    Scand J Urol Nephrol; 1988; 22(4):265-70. PubMed ID: 3238331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneic expression of blood group A and H isoantigens in bladder tumors: association with nuclear volume.
    Orntoft TF; Nielsen K
    J Histochem Cytochem; 1989 Jul; 37(7):1153-5. PubMed ID: 2732458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ABO (H) blood group antigens and carcinoembryonic antigens as indicators of malignant potential in patients with transitional cell carcinoma of the bladder.
    Nakatsu H; Kobayashi I; Onishi Y; Igawa M; Ito H; Tahara E; Nihira H
    J Urol; 1984 Feb; 131(2):252-7. PubMed ID: 6366250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Correlations between grading and presence of blood group isoantigens in papillary urothelial-cell carcinoma of the bladder with low grade malignancy].
    Mattarozzi A; Zanella L; Bacchini P; Bertoni F; Ferramosca B
    Pathologica; 1985; 77(1050):395-400. PubMed ID: 3834371
    [No Abstract]   [Full Text] [Related]  

  • 29. Association of ABO (H) antigen negative transitional cell tumours with abnormal mucosal biopsies in superficial bladder cancer.
    Das G
    Arch Ital Urol Nefrol Androl; 1988 Sep; 60(3):295-9. PubMed ID: 2975863
    [No Abstract]   [Full Text] [Related]  

  • 30. The relationship of ABH(O) blood group antigen expression in intraepithelial dysplastic lesions to clinicopathologic properties of associated transitional cell carcinoma of the bladder.
    Yamada T; Fukui I; Kobayashi T; Sekine H; Yokogawa M; Yamada T; Oshima H
    Cancer; 1991 Mar; 67(6):1661-6. PubMed ID: 2001555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ABH isoantigens, histology and DNA ploidy in 36 consecutive patients with transitional cell bladder cancer. Status of tumor and biopsies taken from visually normal urothelium.
    Borgström E; Nyman C; Lönn M
    Urol Res; 1987; 15(4):199-202. PubMed ID: 3672667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison between the methods of indirect immunofluorescence and specific red cell adherence in detecting ABH iso-antigens in bladder carcinoma.
    Cooper HS; D'Elia FL
    Am J Clin Pathol; 1982 May; 77(5):548-54. PubMed ID: 7044101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Red cell surface antigen and its relationship to survival of patients with transitional cell carcinoma of the bladder.
    Askari A; Colmenares E; Saberi A; Jarman WD
    J Urol; 1981 Feb; 125(2):182-4. PubMed ID: 7206050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isoantigens A, B and H in urinary bladder carcinomas following radiotherapy.
    Alroy J; Teramura K; Miller AW; Pauli BU; Gottesman JE; Flanagan M; Davisohn I; Weinstein RS
    Cancer; 1978 May; 41(5):1739-45. PubMed ID: 647623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A B H isoantigens in bladder cancer. Preliminary study].
    Hernáez Manrique I; Rodríguez Trinidad A; Gastaminza A; Recarte Mendiluce JM
    Actas Urol Esp; 1983; 7(2):113-6. PubMed ID: 6880907
    [No Abstract]   [Full Text] [Related]  

  • 36. Rapid peroxidase-antiperoxidase method for determination of ABH tissue isoantigens.
    Gavris V; Ucci AA; Safaii H; Heaney JA; Alroy J
    Stain Technol; 1983 Mar; 58(2):114-7. PubMed ID: 6194582
    [No Abstract]   [Full Text] [Related]  

  • 37. A, B, H antigen expression in transitional cell carcinomas of the urinary bladder.
    Juhl BR; Hartzen SH; Hainau B
    Cancer; 1986 May; 57(9):1768-75. PubMed ID: 2420436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigenic deletion and prognosis of patients with stage A transitional cell bladder carcinoma.
    Decenzo JM; Howard P; Irish CE
    J Urol; 1975 Dec; 114(6):874-8. PubMed ID: 1195466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A, B, O (H) antigenic determinants in superficial transitional cell tumors of bladder.
    Selli C; Cozzolino F; Vercelli D; Mincione GP
    Urology; 1983 Feb; 21(2):132-4. PubMed ID: 6186066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of ABH tissue isoantigens by immunoperoxidase methods in normal and neoplastic urothelium. Comparison with the erythrocyte adherence method.
    Coon JS; Weinstein RS
    Am J Clin Pathol; 1981 Aug; 76(2):163-71. PubMed ID: 7023226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.